Aerska

RNA medicines to treat, delay, and prevent diseases of the brain

Dublin, Ireland · Founded 2025 · $60.0M raised

Headquarters
Dublin
Employees
11–50
Founded
2025
Business Model
B2B
Website
aerska.com
Total Funding
$60.0M
Last Round
$39.0M Series AFeb 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Aerska is a Dublin-based biotechnology company developing next-generation RNA interference (RNAi) medicines to treat, delay, and prevent diseases of the brain. The company's platform combines systemic administration with proprietary brain delivery technology to shuttle RNAi payloads across the blood-brain barrier, enabling targeted gene silencing in the central nervous system. Founded in 2025 by Jack O'Meara, Stuart Milstein, and David Hardwicke — veterans of Ochre Bio, Alnylam, and AveXis — Aerska launched with $21 million in seed funding and followed with a $39 million Series A in early 2026 to advance its pipeline against neurological diseases including Alzheimer's.

Summary

Aerska is a Biotech company based in Dublin, Ireland, founded in 2025. It has raised $60.0M in total across 2 rounds, most recently a $39.0M Series A round in Feb 2026. Investors include EQT Dementia Fund and EQT Life Sciences.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AFeb 2026
$39.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aerska on Indexed.vc
<a href="https://indexed.vc/companies/aerska"><img src="https://indexed.vc/api/badge/company/aerska" alt="Aerska on Indexed.vc" width="260" height="76" /></a>